로딩 중…
지수 로딩 중…
Precigen, Inc.
PGEN· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$4.81+1.69%
2026-06-18
Price Chart
Precigen, Inc.+222.82%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.71B |
| Revenue | $32M |
| Net Income | $-204M |
| Total Assets | $139M |
| Net Assets | $20M |
| Value | |
| P/B | 84.75x |
| P/S | 54.27x |
| FCF Yield | -6.86% |
| Profitability | |
| Op. Margin | -297.21% |
| Revenue Growth | 1633.93% |
| Financial Health | |
| Debt Ratio | 585.09% |
| Total Debt | $98M |
| FCF | $-118M |
| Cash | $7M |
| Current Ratio | 4.82x |
| Performance | |
| 1Y Return | 222.82% |
| 1M Return | 15.62% |
| From 52W High | -12.07% |
| 1Y MDD | -40.50% |
| Trading | |
| Volume | 4,201,541 shares |
| Trading Value | $20M |
| Per Share | |
| EPS | $-0.77 |
| BPS | $0.14 |